INOGEN INC (INGN)

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Inogen Breaks Below 200-Day Moving Average - Notable for INGN

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Inogen stock rallies 22% as William Blair ups rating to outperform (NASDAQ:INGN)

Shares of Inogen (INGN) were up 22% in afternoon trading Thursday after William Blair upgraded the stock to outperform, citing rival Phillips (PHG) Respironics’

Commit To Purchase Inogen At $7.50, Earn 39.8% Annualized Using Options

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Inogen names Michael Bourque as CFO (NASDAQ:INGN)

Inogen appoints Michael Bourque as CFO, replacing interim finance chief, Mike Sergesketter.

Inogen Names Michael Bourque as New Chief Financial Officer

Notable Friday Option Activity: LOPE, MPW, INGN

Notable Thursday Option Activity: RH, INGN, AVGO

Commit To Buy Inogen At $5, Earn 13.3% Annualized Using Options

Inogen appoints Smith as its CEO (NASDAQ:INGN)

Inogen announces appointment of Kevin Smith as new president and CEO, bringing over 20 years of medical device industry experience.

Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO

Inogen to Present at Upcoming Investor Conferences in November 2023

Inogen Announces Third Quarter 2023 Financial Results

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Inogen Becomes Oversold (INGN)

Inogen Completes Acquisition of Physio-Assist

Inogen Announces CFO Transition Plan

RSI Alert: Inogen (INGN) Now Oversold

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

Inogen Announces Second Quarter 2023 Financial Results